Growth in Improvement in Healthcare Infrastructure Expected to Drive Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Ken Research Amyotrophic lateral sclerosis, or ALS, is an uncommon neurological disorder that mainly affects the nerve cells that control voluntary muscle movements. The voluntary muscles are responsible for producing movements that include walking, chewing, and talking. This disease is very progressive, which means that symptoms get worse over time. ALS is categorized to a group of… Read More »
Rise in Prevalence of Hypertension Expected to Drive Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Ken Research Amyotrophic lateral sclerosis is a nervous system disorder that progressively degenerates muscles and affects the functioning of the physical body. The disease is also acknowledged as motor neuron or Lou Gehrig’s disease. ALS occurs mainly in the 40-60 age groups and can sometimes develop at a young age also due to the inheritance of genetic… Read More »
Growth in Geriatric Populations Expected to Drive North-America Amyotrophic Lateral Sclerosis Treatment Market: Ken Research Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder/disease that damages the nerve cells in central nervous system, which is responsible to control the voluntary muscles. Symptoms of ALS are muscle twitching and muscles decreasing in the size. Medications are also prescribed to control ALS symptoms such as pain, stiffness, muscle cramps, excess saliva & phlegm,… Read More »
Rise in Incidence of Amyotrophic Lateral Sclerosis Expected to Drive Global Amyotrophic Lateral Sclerosis Treatment Market: Ken Research Amyotrophic lateral sclerosis or ALS is a neurodegenerative disorder/disease, which is a most common type of motor neuron disease (MND). ALS can occur in humans due to mutations in the gene that encodes the enzyme copper-zinc superoxide dismutase (CuZnSOD), which is associated with defect in chromosome & genetic inheritance. This type disease is more common… Read More »
